Christopher Crane, MD, is an Attending in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center focusing on gastrointestinal cancer. He has published over 200 papers in peer-reviewed journals with an H-index of 79. His highest impact research focus has been on the use of novel radiation technologies to deliver ablative radiation doses for inoperable pancreatic and liver cancers in order to provide a curative alternative to surgery.